Regression-to-the-mean - A topic in cancer research?;Regression zur mitte - Ein thema in der krebsforschung?

Deutsche Zeitschrift fur Onkologie

Volumn 37, Issue 4, 2005, Pages 169-175

  Lüdtke, Rainer ^a,c   Ostermann, Thomas ^b  

^a Karl und Veronica Carstens Stiftung   (Belgium)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c NONE   (Belgium)

Author keywords

Outcome; Regression to the mean; Screening; Selection

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CANCER RESEARCH; DATA ANALYSIS; ERROR; GENERAL CONDITION IMPROVEMENT; HUMAN; ONCOLOGY; PROBABILITY; REGRESSION TO THE MEAN; SCREENING; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; TREATMENT OUTCOME; VARIANCE;

EID: 29244480302     PISSN: 16175891     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918020     Document Type: Article

References (26)

1. Bankhead C, Brett J, Bukach C, Webster P, Stewart-Brown S, Munafo M, Austoker J: The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Health Technol Assess. 2003;7(42):1-92.
2. Barnett A, van der Pols J, Dobson A: Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34:215-220.
3. Beer T, Myrthue A: Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Then 2004; 3(3):373-381.
4. Catalona W, Richie J, Ahmann F, Hudson M, Scardino P, Flanigan R, deKernion J, Ratliff T, Kavoussi L, Dalkin B: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151(5):1283-1290.
5. Cysarz D, Heckmann C, Bettermann H, Kümmell H: Effects of an anthroposophical remedy on cardiorespiratory regulation. Altern Ther Health Med. 2002;8(6):78-83.
6. Dannehl K: Experimental study versus non-experimental study - The non-experimental (non-randomized) study as a methodological compromise. In: Abel U, Koch A (eds.): Nonrandomized Clinical Studies. Düsseldorf: Symposion Publishing; 1998. p. 41-52.
7. Gutenbrunner C, Ruppel K: Zur Frage der adaptiven Blutdrucknormalisierung im Verlauf von komplexen Bäderkuren unter besonderer Berücksichtigung von Homogenisierungseffekten und Lebensalter. Phys Rehab Kur Med. 1992;2:58-64.
8. Hildebrand G: Physiologische Grundlagen der Rehabilitation. Z Phys Med. 1976;5:215-228.
9. Hoff F: Wirkprinzipien der Therapie. Arch Phys Ther. 1969;21:205-215.
10. Jacobs A, Gold P, Weiden P, Aboulafia D, Rudolph R, Picozzi V, Thompson J: Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer. Cancer Invest. 2000;18(5):417-21.
11. Johnson A: Placebo Effects in Clinical Trials: Just Regression to the Mean? Epilepsia. 1995;36(suppl. 3):S58.
12. Keren G, Teigen KH: The probability-outcome correspondence principle: A dispositional view of the interpretation of probability statements. Memory & Cognition. 2001;29:1010-1021.
13. Klein E, Thompson I: Update on chemoprevention of prostate cancer. Curr Opin Urol. 2004;14(3):143-149.
14. Knoke J, Gray G, Garland F: Testicular cancer and Persian Gulf War service. Epidemiology. 1998;9(6):648-653.
15. Lasserre V, Guihenneuc-Jouyaux C, Richardson S: Biases in ecological studies: utility of including within-area distribution of confounders. Stat Med. 2000;19(1):45-59.
16. Lindgren A, Pukkala E, Nissinen A, Tuomilehto J: Blood Pressure, Smoking, and the Incidence of Lung Cancer in Hypertensive Men in North Karelia, Finland. Am J Epidemiol. 2003;158:442-447.
17. Matthiessen PF: Die Diagnose - eine prognoseorientierte individuelle Therapieentscheidung. System Familie. 1998;11:60-69.
18. Matthiessen PF: Der diagnostisch-therapeutische Prozess als Problem der Einzelfallforschung. In: Ostermann T, Matthiessen PF (eds.): Einzelfallforschung in der Medizin-Bedeutung, Möglichkeiten und Grenzen. Frankfurt: VAS-Verlag; 2003: 31-59.
19. McDonald C, Mazzuca S: How much of the placebó effect́ is really statistical regression? Stat Med. 1983;2:417-427.
20. Mee R, Chua T: Regression Toward the Mean and the Paired Sample t Test Am Statistician. 1991;45(1):39-42.
21. Roush G, Pero R, Powell J, Halper M, Baraldi C, Webb U Miller D: Modulation of the cancer susceptibility measure, adenosine diphosphate ribosyl transferase (ADPRT), by differences in low-dose n-3 and n-6 fatty acids. Nutr Cancer. 1991;16(3-4):197-207.
22. Schröder F: Prostate Cancer. In: Kramer BS GJ, Prorok PC (eds.): Cancer screening, theory and practice. New York: Marcel Dekker Inc; 1999. p. 461-514.
23. Senn S: Regression to the mean. Stat Meth Med Res. 1997;6(2):99-183.
24. Stadler W: Renal cancer immunotherapy: a ray of hope or regression to the mean? Cancer Invest. 2000; 18(5):490-491.
25. Stigler S: Regression towards the mean, historically considered. Stat Meth Med Res. 1997;6(2):103-114.
26. Teigen KH, Brun W: Verbal expressions of probability and uncertainty. In: Hardman D, Macchi L (eds.): Thinking: Psychological perspectives on reasoning, judgment, and decision making. Chichester: Wiley; 2003:125-145.